Watchful waiting, RO7198457 (autogene cevumeran)
BNT122-01
Phase 2 small_molecule active
Quick answer
Watchful waiting, RO7198457 (autogene cevumeran) for Stage II/Stage III rectal cancer or Stage II (high risk)/Stage III colon cancer is a Phase 2 program (small_molecule) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- Stage II/Stage III rectal cancer or Stage II (high risk)/Stage III colon cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active